Onesource Specialty Pharma Stock Screener | Share Price & Fundamental Analysis
ONESOURCE
Pharmaceuticals
Share Price NSE
₹1269.70
▼
-55.40 (-4.18%)
Share Price BSE
₹1266.50
▼
-65.55 (-4.92%)
Track Onesource Specialty Pharma share price live with TickJournal's free stock screener.
Analyze Onesource Specialty Pharma share price history trends and compare 52-week high low
levels.
Calculate ONESOURCE stock fair value using fundamental analysis and view live share price charts.
Determine Onesource Specialty Pharma share intrinsic value and compare it with current ONESOURCE share price.
Record your Onesource Specialty Pharma trades in TickJournal's free trading journal and track your portfolio performance.
Onesource Specialty Pharma Market Cap
₹13,580.63 Cr.
ONESOURCE P/E Ratio (TTM)
696.31
EPS (TTM)
₹-1.63
Dividend Yield
-
Debt to Equity
0.21
ONESOURCE 52 Week High
₹2197.80
Onesource Specialty Pharma 52 Week Low
₹1114.00
Operating Margin
4.00%
Profit Margin
-30.17%
ONESOURCE Revenue (TTM)
₹295.00
EBITDA
₹15.00
Net Income
₹-89.00
Total Assets
₹7,550.00
Total Equity
₹5,881.00
Onesource Specialty Pharma Share Price History - Stock Screener Chart
Screen ONESOURCE historical share price movements with interactive charts. Analyze price trends and patterns.
Onesource Specialty Pharma Company Profile - Fundamental Screener
Screen Onesource Specialty Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ONESOURCE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE013P01021
Onesource Specialty Pharma Balance Sheet Screener
Screen ONESOURCE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 7,550 | 1,309 | 2,009 | 2,442 | 1,258 | 972 |
| Current Assets | 1,086 | 176 | 228 | 511 | 99 | 25 |
| Fixed Assets | 6,118 | 863 | 1,361 | 1,231 | 633 | 354 |
| Liabilities | ||||||
| Total Liabilities | 7,550 | 1,309 | 2,009 | 2,442 | 1,258 | 972 |
| Current Liabilities | 556 | 282 | 358 | 621 | 321 | 361 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 5,881 | 396 | 786 | 1,013 | 776 | 417 |
| Share Capital | 11 | 4 | 4 | 3 | 2 | 1 |
| Reserves & Surplus | 5,869 | 392 | 781 | 1,009 | 775 | 414 |
Onesource Specialty Pharma Income Statement Screener - Profit & Revenue Analysis
Screen Onesource Specialty Pharma income statement and profit fundamentals.
Analyze ONESOURCE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Onesource Specialty Pharma share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 295 | 379 | 333 | 429 | 399 | 338 | 296 | 76 | 88 | 34 | 10 |
| Expenses | 280 | 269 | 242 | 244 | 351 | 263 | 233 | 76 | 173 | 105 | 80 |
| EBITDA | 15 | 110 | 91 | 185 | 48 | 76 | 64 | 0 | -85 | -71 | -70 |
| Operating Profit % | 4.00% | 28.00% | 26.00% | 43.00% | 11.00% | 21.00% | 20.00% | -4.00% | -207.00% | -210.00% | -800.00% |
| Depreciation | 70 | 70 | 68 | 69 | 69 | 68 | 68 | 20 | 20 | 18 | 19 |
| Interest | 38 | 34 | 28 | 33 | 46 | 45 | 42 | 21 | 26 | 25 | 18 |
| Profit Before Tax | -93 | 6 | -4 | 83 | -67 | -38 | -47 | -40 | -130 | -114 | -107 |
| Tax | -4 | -5 | -4 | -16 | 2 | 5 | -41 | 0 | 0 | 0 | 0 |
| Net Profit | -89 | 11 | 0 | 99 | -69 | -42 | -6 | -40 | -130 | -114 | -107 |
| EPS | -7.74 | 0.92 | -0.02 | 8.61 | -6.31 | -10.13 | -0.51 | -9.67 | -31.32 | -27.37 | 0.00 |
Onesource Specialty Pharma Cash Flow Screener - Liquidity Fundamentals
Screen ONESOURCE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | -68 | -107 | -163 | -416 | -118 |
| Investing Activities | -201 | 511 | -68 | -692 | -207 |
| Financing Activities | 412 | -391 | 118 | 1,162 | 381 |
| Net Cash Flow | 143 | 13 | -112 | 55 | 56 |
Onesource Specialty Pharma Shareholding Pattern Screener
See Onesource Specialty Pharma shareholding pattern with promoter, FII, and DII holdings.
Check Onesource Specialty Pharma promoter holding and ownership changes for ONESOURCE on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Dec |
|---|---|---|---|---|---|
| Promoter Holding | 34.25% | 29.79% | 29.77% | 29.93% | 37.77% |
| FII Holding | 18.54% | 18.69% | 19.39% | 19.24% | 17.44% |
| DII Holding | 18.04% | 18.10% | 18.49% | 18.81% | 12.56% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 12.50% | 13.25% | 12.42% | 12.39% | 13.05% |
| Other Holding | 16.67% | 20.17% | 19.93% | 19.63% | 19.18% |
| Shareholder Count | 82,712 | 87,760 | 87,416 | 84,595 | 98,425 |
Onesource Specialty Pharma Share Dividend Screener - Share Yield Analysis
Check Onesource Specialty Pharma dividend history with payout and yield data.
View Onesource Specialty Pharma dividend details including ex-dates and amounts for ONESOURCE stock.
Onesource Specialty Pharma Stock Index Membership
See which indices include Onesource Specialty Pharma stock.
Check ONESOURCE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Onesource Specialty Pharma Market Events Screener - Corporate Actions
Get Onesource Specialty Pharma corporate actions including splits, bonuses, and buybacks.
Check Onesource Specialty Pharma stock events that may affect ONESOURCE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.03% | ||
| 2026-01-23 | 2026-01-23 | Quarterly Result Announcement | NA | -12.34% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | -1.91% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | -7.38% |
| 2025-05-05 | 2025-05-05 | Quarterly Result Announcement | NA | -0.05% |
| 2025-01-29 | 2025-01-29 | Quarterly Result Announcement | NA | - |
| 2024-02-14 | 2024-02-14 | Change Of Name | NA | - |
Onesource Specialty Pharma Competitors Screener - Peer Comparison
Screen ONESOURCE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 407,287 | 37.56 | 54,729 | 9.71% | 10,980 | 52.49 |
| Divis Laboratories | 163,754 | 66.27 | 9,712 | 18.67% | 2,191 | 48.87 |
| Torrent Pharmaceuticals | 138,018 | 64.55 | 11,539 | 6.99% | 1,911 | 59.36 |
| Cipla | 107,555 | 23.69 | 28,410 | 7.12% | 5,291 | 35.86 |
| Dr Reddys Laboratories | 105,839 | 19.26 | 33,741 | 16.73% | 5,725 | 58.24 |
| Lupin | 100,464 | 23.23 | 22,910 | 13.74% | 3,306 | 56.93 |
| Zydus Life Science | 91,034 | 18.43 | 23,511 | 18.55% | 4,615 | 51.32 |
| Mankind Pharma | 85,058 | 47.59 | 12,744 | 20.90% | 2,007 | 42.02 |
| Aurobindo Pharma | 66,537 | 19.29 | 32,346 | 9.43% | 3,484 | 45.13 |
| Alkem Laboratories | 64,595 | 29.06 | 13,458 | 3.70% | 2,216 | 36.02 |
Onesource Specialty Pharma Company Announcements - News Screener
Screen ONESOURCE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-19 | Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2026-02-18 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-12 | Onesource Specialty Pharma Limited Has Informed The Exchange Regarding Disclosure Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares & Takeovers)Regulations 2011 And Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2 | View |
| 2026-02-12 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-02-04 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-02-04 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-02-03 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-02-03 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-01-28 | Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations 2011 And Regulation 7(2) Of SEBI (PIT) Regulations 2015 | View |
| 2026-01-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-24 | Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | View |
| 2026-01-24 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-01-24 | Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | View |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-23 | Board Meeting Outcome for Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2025 | View |
| 2026-01-21 | Allotment Of Equity Shares Under The Onesource Specialty Pharma Limited - Employee Stock Option Plan - 2021 | View |
| 2026-01-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-19 | Board Meeting Intimation for Intimation Of The Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015 For Approval Of Unaudited Financial Results Of The Company For The Quarter Ended December 31 2 | View |